mitoxantrone has been researched along with Lymphoma of Mucosa-Associated Lymphoid Tissue in 12 studies
Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Patients with histologically verified MALT lymphoma undergoing chemotherapy with MCP were evaluated retrospectively." | 5.32 | Treatment of extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) with mitoxantrone, chlorambucil and prednisone (MCP). ( Chott, A; Dirisamer, A; Drach, J; Hejna, M; Püspök, A; Raderer, M; Scheithauer, W; Wöhrer, S, 2003) |
| " The most common adverse effects were hematologic, with 2 patients experiencing treatment-related myelodysplastic syndrome (MDS), evolving to acute myelogenous leukemia (AML) in 1 patient." | 2.76 | Safety and efficacy of combination therapy with fludarabine, mitoxantrone, and rituximab followed by yttrium-90 ibritumomab tiuxetan and maintenance rituximab as front-line therapy for patients with follicular or marginal zone lymphoma. ( Bayer, R; Fung, HC; Gregory, SA; Karmali, R; Kassar, M; O'Brien, T; Shammo, JM; Venugopal, P, 2011) |
| "Cladribine is a newer purine analogue and is of particular interest because it is resistant to deamination by adenosine deaminase." | 2.42 | Treatment of indolent non-Hodgkin's lymphoma with cladribine as single-agent therapy and in combination with mitoxantrone. ( Armitage, JO; Hoelzer, D; Rummel, MJ; Tobinai, K, 2004) |
| "A 47 year old woman with a MALT lymphoma affecting the breast exclusively is reported." | 2.40 | [Primary MALT-type lymphoma of the breast]. ( Campo, E; Cervantes, F; Esteve, J; Montserrat, E; Rafel, M; Serra, A; Velasco, M, 1998) |
| "There were 32 small lymphocytic lymphomas and 111 marginal zone lymphomas." | 1.42 | Fludarabine-Mitoxantrone-Rituximab regimen in untreated indolent non-follicular non-Hodgkin's lymphoma: experience on 143 patients. ( Argnani, L; Broccoli, A; Casadei, B; Gandolfi, L; Maglie, R; Pellegrini, C; Pileri, S; Stefoni, V; Zinzani, PL, 2015) |
| "We present a patient with MALT lymphoma of the salivary glands who also had multiple calculi in the parotid glands." | 1.33 | Multiple bilateral parotid sialoliths in a patient with mucosa-associated lymphoid tissue lymphoma (MALT lymphoma) of the salivary glands. ( Drage, NA; Howarth, A; Wickramasinghe, A, 2005) |
| "As no data on this topic exist for MALT lymphoma, we have retrospectively analysed our experience with R plus cyclophosphamide, doxorubicin/mitoxantrone, vincristine and prednisone (R-CHOP/R-CNOP) in patients with relapsed MALT lymphoma." | 1.33 | Activity of rituximab plus cyclophosphamide, doxorubicin/mitoxantrone, vincristine and prednisone in patients with relapsed MALT lymphoma. ( Chott, A; Drach, J; Jager, U; Puspok, A; Raderer, M; Streubel, B; Troch, M; Turetschek, K; Wohrer, S; Zielinski, CC, 2006) |
| "Patients with histologically verified MALT lymphoma undergoing chemotherapy with MCP were evaluated retrospectively." | 1.32 | Treatment of extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) with mitoxantrone, chlorambucil and prednisone (MCP). ( Chott, A; Dirisamer, A; Drach, J; Hejna, M; Püspök, A; Raderer, M; Scheithauer, W; Wöhrer, S, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (8.33) | 18.2507 |
| 2000's | 8 (66.67) | 29.6817 |
| 2010's | 3 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zinzani, PL | 2 |
| Pellegrini, C | 2 |
| Broccoli, A | 2 |
| Gandolfi, L | 2 |
| Stefoni, V | 2 |
| Casadei, B | 2 |
| Maglie, R | 1 |
| Argnani, L | 2 |
| Pileri, S | 2 |
| Karmali, R | 1 |
| Kassar, M | 1 |
| Venugopal, P | 1 |
| Shammo, JM | 1 |
| Fung, HC | 1 |
| Bayer, R | 1 |
| O'Brien, T | 1 |
| Gregory, SA | 1 |
| Derenzini, E | 1 |
| Quirini, F | 1 |
| Celli, M | 1 |
| Fanti, S | 1 |
| Poletti, V | 1 |
| Baccarani, M | 1 |
| Wöhrer, S | 3 |
| Drach, J | 3 |
| Hejna, M | 2 |
| Scheithauer, W | 1 |
| Dirisamer, A | 1 |
| Püspök, A | 2 |
| Chott, A | 2 |
| Raderer, M | 3 |
| Armitage, JO | 1 |
| Tobinai, K | 1 |
| Hoelzer, D | 1 |
| Rummel, MJ | 1 |
| Wickramasinghe, A | 1 |
| Howarth, A | 1 |
| Drage, NA | 1 |
| Bartsch, R | 1 |
| Streubel, B | 1 |
| Jager, U | 1 |
| Turetschek, K | 1 |
| Troch, M | 1 |
| Zielinski, CC | 1 |
| Roussel, B | 1 |
| Bettembourg, O | 1 |
| Cochard, C | 1 |
| Cochener, B | 1 |
| Economopoulos, T | 1 |
| Psyrri, A | 1 |
| Fountzilas, G | 1 |
| Tsatalas, C | 1 |
| Anagnostopoulos, A | 1 |
| Papageorgiou, S | 1 |
| Xiros, N | 1 |
| Dimopoulos, MA | 1 |
| Lü, SQ | 1 |
| Yang, JM | 1 |
| Song, XM | 1 |
| Chen, L | 1 |
| Zhang, WP | 1 |
| Ni, X | 1 |
| Xu, XQ | 1 |
| Wang, JM | 1 |
| Rafel, M | 1 |
| Esteve, J | 1 |
| Cervantes, F | 1 |
| Velasco, M | 1 |
| Serra, A | 1 |
| Campo, E | 1 |
| Montserrat, E | 1 |
2 reviews available for mitoxantrone and Lymphoma of Mucosa-Associated Lymphoid Tissue
| Article | Year |
|---|---|
Treatment of indolent non-Hodgkin's lymphoma with cladribine as single-agent therapy and in combination with mitoxantrone.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cladribine; Humans; Leukemia, Lymphocytic, Chronic, | 2004 |
[Primary MALT-type lymphoma of the breast].
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cycloph | 1998 |
2 trials available for mitoxantrone and Lymphoma of Mucosa-Associated Lymphoid Tissue
| Article | Year |
|---|---|
Safety and efficacy of combination therapy with fludarabine, mitoxantrone, and rituximab followed by yttrium-90 ibritumomab tiuxetan and maintenance rituximab as front-line therapy for patients with follicular or marginal zone lymphoma.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined | 2011 |
Phase II study of low-grade non-Hodgkin lymphomas with fludarabine and mitoxantrone followed by rituximab consolidation: promising results in marginal zone lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Disease-Free Survival; Female; Humans; Lymphoma, B-Cell, Marginal Zo | 2008 |
8 other studies available for mitoxantrone and Lymphoma of Mucosa-Associated Lymphoid Tissue
| Article | Year |
|---|---|
Fludarabine-Mitoxantrone-Rituximab regimen in untreated indolent non-follicular non-Hodgkin's lymphoma: experience on 143 patients.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Surviva | 2015 |
Extranodal marginal zone B-cell lymphoma of the lung: experience with fludarabine and mitoxantrone-containing regimens.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Disease-Free S | 2013 |
Treatment of extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) with mitoxantrone, chlorambucil and prednisone (MCP).
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Dis | 2003 |
Multiple bilateral parotid sialoliths in a patient with mucosa-associated lymphoid tissue lymphoma (MALT lymphoma) of the salivary glands.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dexamethasone; Doxorubicin; Female | 2005 |
Routine application of the proton-pump inhibitor pantoprazole in patients with gastric lymphoma undergoing chemotherapy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adult; Aged; Aged, 80 and over; Anti- | 2005 |
Activity of rituximab plus cyclophosphamide, doxorubicin/mitoxantrone, vincristine and prednisone in patients with relapsed MALT lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Anti | 2006 |
[MALT (mucosa-associated lymphoid tissue) lymphoma of the lacrimal gland].
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemot | 2007 |
[A clinical observation of fludarabine-containing regimens in the treatment of low grade non-Hodgkin's lymphoma].
Topics: Adult; Aged; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dexa | 2007 |